Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 924,387
  • Shares Outstanding, K 40,490
  • Annual Sales, $ 726,410 K
  • Annual Income, $ 7,030 K
  • EBIT $ 76 M
  • EBITDA $ 166 M
  • 60-Month Beta 0.21
  • Price/Sales 1.25
  • Price/Cash Flow 5.82
  • Price/Book 1.39

Options Overview Details

View History
  • Implied Volatility 61.06% (-20.21%)
  • Historical Volatility 34.92%
  • IV Percentile 41%
  • IV Rank 27.27%
  • IV High 119.80% on 10/30/25
  • IV Low 39.03% on 08/20/25
  • Expected Move (DTE 8) 3.32 (14.13%)
  • Put/Call Vol Ratio 0.75
  • Today's Volume 7
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 1,144
  • Open Int (30-Day) 1,155
  • Expected Range 20.15 to 26.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.39
  • Number of Estimates 2
  • High Estimate 0.45
  • Low Estimate 0.33
  • Prior Year 0.39
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.62 +14.11%
on 02/27/26
23.73 -0.84%
on 02/26/26
+2.08 (+9.70%)
since 02/12/26
3-Month
18.80 +25.16%
on 01/20/26
27.16 -13.36%
on 12/16/25
-2.76 (-10.50%)
since 12/12/25
52-Week
18.80 +25.16%
on 01/20/26
27.64 -14.87%
on 09/03/25
+1.49 (+6.76%)
since 03/12/25

Most Recent Stories

More News
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.

Pacira's Stock is Down 56% Over the Last Decade and Down 68% Over the Last 5 Years [i] ; Under the Leadership of CEO and Board Member Frank Lee, the Stock Has Fallen 30% [ii] ...

PCRX : 23.54 (+3.11%)
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation

-- Issues Statement in Response to DOMA’s Nomination of Director Candidates --  -- No Shareholder Action Required at This Time -- BRISBANE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Pacira...

PCRX : 23.54 (+3.11%)
DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.

Pacira's Stock is Down 56% Over the Last Decade and Down 68% Over the Last 5 Years i ; Under the Leadership of CEO and Board Member Frank Lee, the Stock Has Fallen 30% ii ;...

PCRX : 23.54 (+3.11%)
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients,...

PCRX : 23.54 (+3.11%)
Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference

BRISBANE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives...

PCRX : 23.54 (+3.11%)
Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR)

-- Studies highlight the clinical effectiveness of EXPAREL for total knee arthroplasty and long-term pain management with iovera º for patients with osteoarthritis (OA) of the knee -- -- Data...

PCRX : 23.54 (+3.11%)
Pacira: Q4 Earnings Snapshot

Pacira: Q4 Earnings Snapshot

PCRX : 23.54 (+3.11%)
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results

— Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years — — Conference call today at 4:30 p.m. ET — BRISBANE, Calif.,...

PCRX : 23.54 (+3.11%)
Pacira to Report 2025 Financial Results on Thursday February 26, 2026

BRISBANE, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives...

PCRX : 23.54 (+3.11%)
Pacira Highlights New NOPAIN Act Survey Data Conducted by Voices for Non-Opioid Choices

BRISBANE, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies, today highlighted...

PCRX : 23.54 (+3.11%)

Business Summary

Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers. These products are developed using the company's proprietary DepoFoam drug...

See More

Key Turning Points

3rd Resistance Point 23.83
2nd Resistance Point 23.36
1st Resistance Point 23.10
Last Price 23.54
1st Support Level 22.36
2nd Support Level 21.88
3rd Support Level 21.62

See More

52-Week High 27.64
Fibonacci 61.8% 24.26
Last Price 23.54
Fibonacci 50% 23.22
Fibonacci 38.2% 22.18
52-Week Low 18.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar